About Tagra Biotechnologies
Located at 8 Ha-Melakha Street in Netanya, Israel, Tagra Biotechnologies leads innovation in microencapsulation technology for cosmetic applications. The research facility offers:
- Patented Release on Demand (RND) technology for non-water-soluble ingredients
- Breakable and unbreakable microcapsules using cellulose-based polymers
- Water-soluble compound conversion through complexation
- ISO-certified quality and environmental management systems
From its Center District headquarters, Tagra Biotechnologies serves global cosmetic manufacturers with preservative-free, Halal-certified solutions that meet international compliance standards.
Frequently asked questions
Tagra Biotechnologies develops the following technologies:
- Microencapsulation Systems
- Release on Demand (RND) patented method
- Breakable microcapsules for visual effects
- Unbreakable microcapsules with cellulose-based polymers
- Solubilization Technology
- Conversion of non-water-soluble compounds
- Complexation with polymers
- Medium-chain fatty acid processes
- Delivery Systems
- Microparticulate technologies
- UV filter encapsulation
- Active compound stabilization
All technologies align with global compliance standards and clean label requirements.
Tagra Biotechnologies maintains these certifications and standards:
| Category | Standards |
|---|---|
| Quality Management |
|
| Environmental Standards |
|
| Product Standards |
|
The company holds 14 patents in microparticulate delivery systems.
Tagra Biotechnologies serves global cosmetic markets with these specifications:
- Geographic Coverage
- Global distribution network
- China-compliant formulations
- International regulatory compliance
- Market Segments
- Cosmetic manufacturers
- Skincare formulators
- UV protection developers
- Compliance Regions
- European Union
- North America
- Asia-Pacific
Products meet Halal certification requirements and global regulatory standards.
More details about Tagra Biotechnologies
Tagra Biotechnologies: Advanced solutions for cosmetic formulation
Located in Netanya, Israel, Tagra Biotechnologies operates as a cosmetic lab specializing in innovative ingredient delivery systems. The company’s headquarters in the Center District serves as a hub for their research and development activities.
Technology and expertise
At the core of Tagra Biotechnologies’ operations is their patented microencapsulation technology. Their team of PhDs has developed a Release on Demand (RND) method, resulting in over 14 patents in microparticulate delivery systems.
Microcapsule solutions
The company offers two main types of microcapsule technologies:
- Breakable microcapsules for visual and sensorial effects
- Unbreakable microcapsules using cellulose-based polymers
Services and capabilities
Tagra Biotechnologies provides specialized solutions for:
- Converting non-water-soluble compounds to soluble forms
- Creating stabilized active ingredients for skin care applications
- Developing UV filters with controlled release properties
Quality standards and certifications
The company maintains high operational standards through multiple certifications:
- EN ISO 9001:2015
- EN ISO 14001
- EN ISO 22716:2007
- ECOVADIS Gold Qualification
- RSPO MB
Product compliance and characteristics
All products developed in their facilities are:
- Globally compliant, including China
- Free from preservatives and surfactants
- Halal certified
- Non-nano sized
- Not tested on animals








